Home > Financial Ratios > AARTI PHARMALABS

AARTI PHARMALABS
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for AARTI PHARMALABS
Please provide your vote to see the results

AARTI PHARMALABS Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 20.8417.5817.11-

What is the latest Core EBITDA Margin ratio of AARTI PHARMALABS ?

The latest Core EBITDA Margin ratio of AARTI PHARMALABS is 20.84 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202420.84
Mar202317.58
Mar202217.11
Mar2021-

How is Core EBITDA Margin of AARTI PHARMALABS Trending?

Years Core EBITDA Margin % Change
Mar2024 20.84
18.54
Mar2023 17.58
2.75
Mar2022 17.11
0
Mar2021 0 -

Other Financial Ratios of AARTI PHARMALABS


Compare Core EBITDA Margin ratio of peers of AARTI PHARMALABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI PHARMALABS ₹6,859.8 Cr -10.6% -21.5% 40.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹394,115.0 Cr 3.5% -3.4% -5.8% Stock Analytics
DIVIS LABORATORIES ₹162,735.0 Cr 3.7% -10.2% 25.6% Stock Analytics
CIPLA ₹126,313.0 Cr 5.3% 6.1% -1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,592.0 Cr 1.4% 4.6% 7.6% Stock Analytics
DR REDDYS LABORATORIES ₹105,095.0 Cr 3.9% 0% -9.9% Stock Analytics


AARTI PHARMALABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI PHARMALABS

-10.6%

-21.5%

40.2%

SENSEX

-0%

-2.4%

1.2%


You may also like the below Video Courses